Log in to search using one of your social media accounts:


Personalized Medicine Approach for an Exceptional Response to Multiple-recurrent and Metastatic HER2-positive Oropharyngeal Squamous Cell Carcinoma.

CONCLUSIONS: Molecular tumor analysis is an infrequently utilized tool in head and neck squamous cell carcinoma; however, as understanding of biologic mechanisms improves, additional molecular targets will become available and expand treatment opportunities such as HER2/Neu targeting. The Exceptional Responders Initiative is a unique strategy with potential to expedite progress. PMID: 28061634 [PubMed - as supplied by publisher]
Source: The Annals of Otology, Rhinology, and Laryngology - Category: ENT & OMF Authors: Tags: Ann Otol Rhinol Laryngol Source Type: research

Related Links:

More News: Biology | Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | ENT & OMF | Head and Neck Cancer | HER2 | HNSCC | Molecular Biology | Oropharyngeal Cancer | Skin Cancer | Squamous Cell Carcinoma